HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, today announced it has selected ...

Researchers at the University of Kent have established a computational protocol that could accelerate the development of more ...

Quick Read iShares Biotechnology ETF (IBB) returned 45% over the past year with $8.12B in assets and concentrates in large ...

The only drug named in Trump’s executive order is ibogaine, a psychedelic commonly used to treat depression, anxiety and PTSD ...

Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...

FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

By Maggie Fick LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely ...

Neuroscience trials require high-precision, sensitive endpoint measurements, yet sponsors often face challenges with ...

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.